John Lowe

A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor

R. Michael Snider, Jay W. Constantine, John Lowe et al. · Science · 1991 · 864 citations

Potent Nonpeptide Antagonist, Biochemistry, Functional Selectivity +12

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

David M. Compton, Mario D. Aceto, John Lowe et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 358 citations

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 320 citations

To Wake the Nations: Race in the Making of American Literature.

John Lowe, Eric J. Sundquist · The William and Mary Quarterly · 1994 · 231 citations

Contemporary Racism, Critical Race Theory, Literary History +12

Activity and Distribution of Binding Sites in Brain of a Nonpeptide Substance P (NK ₁ ) Receptor Antagonist

Stafford McLean, Alan H. Ganong, Thomas Seeger et al. · Science · 1991 · 218 citations

Neurotransmitter, Receptor Antagonist, Guinea Pig Brain +18